SLC6A3 and Parkinson disease: In a smaller clinical study, a significant increase in striatal DAT was observed in non-manifesting carriers of the 22q11.2 mutation, which is associated with an age-related increased risk of PD, suggesting that a hyperdopaminergic mechanism may be linked to manifestations of PD and its pathogenesis (Butcher et al., 2017).